Home

Sau fie Neliniştit Controalele cyfra 21 1 tumor marker conducere Legătură Oxid

PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma
PDF) CYFRA 21-1 as a tumour marker for bronchogenic carcinoma

Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody  immune complex for detection of early stage lung cancer - Chemical  Communications (RSC Publishing)
Quantification of CYFRA 21-1 and a CYFRA 21-1–anti-CYFRA 21-1 autoantibody immune complex for detection of early stage lung cancer - Chemical Communications (RSC Publishing)

Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer  - ScienceDirect
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer - ScienceDirect

Cyfra 21-1 as a Tumor Marker for Follow-up of Patients with Squamous Cell  Carcinoma of the Oropharnyx | Anticancer Research
Cyfra 21-1 as a Tumor Marker for Follow-up of Patients with Squamous Cell Carcinoma of the Oropharnyx | Anticancer Research

The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1,  TPS) in Head and Neck Cancer Patients | Anticancer Research
The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients | Anticancer Research

A retrospective analysis of serum tumor markers found in non-small cell  lung cancer
A retrospective analysis of serum tumor markers found in non-small cell lung cancer

KoreaMed Synapse
KoreaMed Synapse

Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting  Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE

CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer:  results of a meta-analysis in 2063 patients | British Journal of Cancer
CYFRA 21-1 is a prognostic determinant in non-small-cell lung cancer: results of a meta-analysis in 2063 patients | British Journal of Cancer

Oncology
Oncology

Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting  Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE
Fine-Needle Aspirates CYFRA 21-1 is a Useful Tumor Marker for Detecting Axillary Lymph Node Metastasis in Breast Cancer Patients | PLOS ONE

CYFRA 21-1 - ABBOTT Diagnostics
CYFRA 21-1 - ABBOTT Diagnostics

CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell  Lung Cancer in a Prospective Trial: CALGB 150304 - ScienceDirect
CYFRA 21-1 as a Prognostic and Predictive Marker in Advanced Non–Small-Cell Lung Cancer in a Prospective Trial: CALGB 150304 - ScienceDirect

Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for  detecting disease relapse and assessing treatment efficacy in breast cancer  | British Journal of Cancer
Serum CYFRA 21-1 (cytokeratin-19 fragments) is a useful tumour marker for detecting disease relapse and assessing treatment efficacy in breast cancer | British Journal of Cancer

Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of  operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J  Can Res Ther
Diagnostic value of CYFRA 21-1 and carcinoembryonic antigen in diagnosis of operable lung cancer from benign lung disease Chen F, Li J, Qi X, Qi J - J Can Res Ther

TM-CYFRA 21-1 ELISA - DRG International, Inc.
TM-CYFRA 21-1 ELISA - DRG International, Inc.

Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal  and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research
Cyfra 21-1 as a Serum Tumor Marker for Follow-up of Patients with Laryngeal and Hypopharyngeal Squamous Cell Carcinoma | Anticancer Research

Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung  cancer. | Semantic Scholar
Diagnostic value of CEA and CYFRA 21-1 tumor markers in primary lung cancer. | Semantic Scholar

CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal  cutoff to assess the diagnostic efficacy and prognostic value
CYFRA 21-1 in patients with suspected cancer: evaluation of an optimal cutoff to assess the diagnostic efficacy and prognostic value

CYFRA 21-1 DISTRIBUTION IN NON-SMALL CELL LUNG CANCER | Download Table
CYFRA 21-1 DISTRIBUTION IN NON-SMALL CELL LUNG CANCER | Download Table

CYFRA 21-1 levels (ng·ml -1 ) in benign lung disease | Download Table
CYFRA 21-1 levels (ng·ml -1 ) in benign lung disease | Download Table

CYFRA 21-1 levels (ng·ml -1 ) in lung cancer according to TNM stage |  Download Table
CYFRA 21-1 levels (ng·ml -1 ) in lung cancer according to TNM stage | Download Table